Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Open Label Non-comparative, Multi-center Trial to Evaluate the Efficacy and Safety of Cipro® XR 500 mg Once Daily for 3 Days in Treating Female Patients With Acute, Uncomplicated, Symptomatic Lower Urinary Tract Infections

NCT00669994 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00669994
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00669994 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Open Label Non-comparative, Multi-center Trial to Evaluate the Efficacy and Safety of Cipro® XR 500 mg Once Daily for 3 Days in Treating Female Patients With Acute, Uncomplicated, Symptomatic Lower Urinary Tract Infections
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2003
Completion date
October 31, 2003
Enrollment
180 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

urinary tract infection